This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Raymond H. Kaufman, MD; Keith O. Reeves, MD; Cary M. Dougherty, MD

JAMA. 1976;236(8):923-926.

Abstract
Of eight young women, seven had a diagnosis of well-differentiated endometrial adenocarcinoma and one had atypical endometrial hyperplasia. The average age was 40.1 years, with 6.04 years of dimethisterone-ethinyl estradiol (Oracon) sequential contraceptive use.

The patients were not typical of those in whom endometrial carcinoma develops. Although these cases do not prove that long-term administration of dimethisterone-ethinyl estradiol causes endometrial adenocarcinoma or atypia, they indicate that it may do so.

(JAMA 236:923-926, 1976)

Author Affiliations
From the Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston (Drs Kaufman and Reeves), and the Department of Obstetrics and Gynecology, Louisiana State University School of Medicine, Baton Rouge (Dr Dougherty).

Footnotes
Reprint requests to Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77025 (Dr Kaufman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?